Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Return on Sales (2021 - 2025)

Historic Return on Sales for Oncology Institute (TOI) over the last 5 years, with Q3 2025 value amounting to 0.12%.

  • Oncology Institute's Return on Sales rose 400.0% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 400.0%. This contributed to the annual value of 0.16% for FY2024, which is 900.0% up from last year.
  • According to the latest figures from Q3 2025, Oncology Institute's Return on Sales is 0.12%, which was up 400.0% from 0.14% recorded in Q2 2025.
  • In the past 5 years, Oncology Institute's Return on Sales registered a high of 0.35% during Q1 2022, and its lowest value of 0.39% during Q1 2023.
  • Moreover, its 5-year median value for Return on Sales was 0.15% (2022), whereas its average is 0.12%.
  • Its Return on Sales has fluctuated over the past 5 years, first soared by 3700bps in 2022, then tumbled by -7400bps in 2023.
  • Over the past 5 years, Oncology Institute's Return on Sales (Quarter) stood at 0.19% in 2021, then increased by 21bps to 0.15% in 2022, then tumbled by -42bps to 0.22% in 2023, then surged by 40bps to 0.13% in 2024, then rose by 8bps to 0.12% in 2025.
  • Its Return on Sales stands at 0.12% for Q3 2025, versus 0.14% for Q2 2025 and 0.19% for Q1 2025.